Helsinki, Finland

Antti Nykanen

This inventor holds 1 USPTO granted patent. Top assignee: Licentia, Ltd.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antti Nykanen. Retrieved from https://idiyas.com/inventor/antti-nykanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antti Nykanen: Innovator in Colorectal Cancer Screening

Introduction

Antti Nykanen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical technology, particularly in colorectal cancer screening and therapy. His innovative work aims to improve the methods used for diagnosing and treating this prevalent disease.

Latest Patents

Antti Nykanen holds a patent for "Materials and methods for colorectal cancer screening, diagnosis and therapy." This invention provides essential materials and methodologies that enhance the screening, diagnosis, and therapeutic processes for colorectal cancer. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Nykanen is currently associated with Licentia Ltd., where he continues to develop innovative solutions in healthcare. His work at the company reflects his dedication to improving patient outcomes through technological advancements.

Collaborations

Antti has collaborated with esteemed colleagues such as Tatiana Petrova and Kari Alitalo. These partnerships highlight the collaborative nature of innovation in the medical field, where diverse expertise contributes to groundbreaking advancements.

Conclusion

Antti Nykanen's contributions to colorectal cancer screening and therapy exemplify the impact of innovation in healthcare. His work not only enhances diagnostic methods but also paves the way for improved treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…